These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 27090048)

  • 21. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention.
    Zhang Q; Hu M; Ma S
    J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
    Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
    Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
    Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
    Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
    Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
    Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
    Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
    J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
    Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R
    Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.
    Zhang H; Qiu B; Zhang Y; Cao Y; Zhang X; Wu Z; Wang S; Mei L
    Med Sci Monit; 2018 Jul; 24():4528-4535. PubMed ID: 29961077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.
    Harrison RW; Aggarwal A; Ou FS; Klein LW; Rumsfeld JS; Roe MT; Wang TY;
    Am J Cardiol; 2013 Jan; 111(2):178-84. PubMed ID: 23111142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.
    Yuksel M; Isik T; Tanboga IH; Ayhan E; Erimsah ME; Topcu S; Demirelli S; Aksakal E; Sevimli S
    Clin Appl Thromb Hemost; 2017 May; 23(4):329-335. PubMed ID: 27418637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Zhang Q; Hu M; Sun J; Ma S
    Scand Cardiovasc J; 2020 Dec; 54(6):352-357. PubMed ID: 32597237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Avanzas P; Bosa-Ojeda F; Kaski JC
    Am J Cardiol; 2010 Dec; 106(11):1540-4. PubMed ID: 21094352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
    Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.